Robertson JS[au] - Search Results

Year	Number of Results
1946	1
1948	2
1950	2
1951	3
1952	4
1953	1
1954	7
1955	3
1956	5
1957	7
1959	4
1960	3
1961	5
1962	4
1963	9
1964	7
1965	1
1966	11
1967	2
1968	5
1969	4
1970	9
1971	5
1972	8
1973	8
1974	9
1975	4
1976	6
1977	5
1978	8
1979	6
1980	6
1981	4
1982	4
1983	11
1984	3
1985	1
1986	1
1987	6
1988	3
1989	5
1990	3
1991	5
1992	5
1993	10
1994	7
1995	4
1996	2
1997	3
1998	4
1999	9
2000	2
2001	2
2002	2
2003	1
2004	2
2005	3
2006	4
2007	2
2008	3
2009	2
2010	2
2011	8
2012	6
2013	7
2014	5
2015	7
2016	6
2017	3
2018	5
2019	4
2020	8
2021	4

1

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.

Kim D, Robertson JS, Excler JL, Condit RC, Fast PE, Gurwith M, Pavlakis G, Monath TP, Smith J, Wood D, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kim D, et al. Among authors: robertson js. Vaccine. 2020 Jul 22;38(34):5556-5561. doi: 10.1016/j.vaccine.2020.06.017. Epub 2020 Jun 19. Vaccine. 2020. PMID: 32571717 Free PMC article. Review.

2

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.

Monath TP, Fast PE, Modjarrad K, Clarke DK, Martin BK, Fusco J, Nichols R, Heppner DG, Simon JK, Dubey S, Troth SP, Wolf J, Singh V, Coller BA, Robertson JS; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Monath TP, et al. Among authors: robertson js. Vaccine X. 2019 Jan 29;1:100009. doi: 10.1016/j.jvacx.2019.100009. eCollection 2019 Apr 11. Vaccine X. 2019. PMID: 31384731 Free PMC article.

3

The INN global nomenclature of biological medicines: A continuous challenge.

Robertson JS, Chui WK, Genazzani AA, Malan SF, López de la Rica Manjavacas A, Mignot G, Thorpe R, Balocco R, Rizzi M. Robertson JS, et al. Biologicals. 2019 Jul;60:15-23. doi: 10.1016/j.biologicals.2019.05.006. Epub 2019 May 23. Biologicals. 2019. PMID: 31130314 Free article. Review.

4

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber DA, Brill AB. Siegel JA, et al. Among authors: robertson js. J Nucl Med. 1999 Feb;40(2):37S-61S. J Nucl Med. 1999. PMID: 10025848 Free article.

5

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.

Kochhar S, Kim D, Excler JL, Condit RC, Robertson JS, Drew S, Whelan M, Wood D, Fast PE, Gurwith M, Klug B, Khuri-Bulos N, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kochhar S, et al. Among authors: robertson js. Vaccine. 2020 Jul 31;38(35):5734-5739. doi: 10.1016/j.vaccine.2020.06.044. Epub 2020 Jul 9. Vaccine. 2020. PMID: 32653276 Free PMC article. Review.

6

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.

Condit RC, Kim D, Robertson JS, Excler JL, Gurwith M, Monath TP, Pavlakis G, Fast PE, Smith J, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Benefit-Risk Assessment of Vaccines by Technology (BRAVATO) Working Group. Electronic address: bc-coordinator@taskforce.org. Condit RC, et al. Among authors: robertson js. Vaccine. 2020 Nov 17;38(49):7708-7715. doi: 10.1016/j.vaccine.2020.08.009. Epub 2020 Sep 6. Vaccine. 2020. PMID: 32907759 Free PMC article. Review.

7

Plant Genome Duplication Database.

Lee TH, Kim J, Robertson JS, Paterson AH. Lee TH, et al. Among authors: robertson js. Methods Mol Biol. 2017;1533:267-277. doi: 10.1007/978-1-4939-6658-5_16. Methods Mol Biol. 2017. PMID: 27987177

8

Transmission Genetics of a Sorghum bicolor × S. halepense Backcross Populations.

Kong W, Nabukalu P, Cox TS, Goff VH, Pierce GJ, Lemke C, Robertson JS, Compton R, Tang H, Paterson AH. Kong W, et al. Among authors: robertson js. Front Plant Sci. 2020 Apr 30;11:467. doi: 10.3389/fpls.2020.00467. eCollection 2020. Front Plant Sci. 2020. PMID: 32425964 Free PMC article.

9

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.

Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG. Gurwith M, et al. Among authors: robertson js. Vaccine. 2020 Nov 17;38(49):7702-7707. doi: 10.1016/j.vaccine.2020.09.042. Epub 2020 Oct 16. Vaccine. 2020. PMID: 33070999 Free PMC article. Review.

10

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.

Kochhar S, Excler JL, Kim D, Robertson JS, Fast PE, Condit RC, Drew S, Wood D, Gurwith M, Klug B, Whelan M, Khuri-Bulos N, Mallett Moore T, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Electronic address: brightoncollaborationv3swg@gmail.com. Kochhar S, et al. Among authors: robertson js. Vaccine. 2020 Sep 3;38(39):6184-6189. doi: 10.1016/j.vaccine.2020.07.028. Epub 2020 Jul 31. Vaccine. 2020. PMID: 32747214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results